In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

In both the Phase 1 and Phase 2 clinical trials no OCU410-related serious adverse events were observed and no cases of endophthalmitis, retinal detachment, vasculitis, choroidal neovascularization, or ...

Ocugen also reported updated results from a phase 1 trial, which showed that ellipsoid zone (EZ) loss – which results in the ...

FREDERICK, MD, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Maryland Vision Institute (MVI) and Busack Eye ...

People with macular degeneration and other forms of central vision loss can see details like text and faces with this device.

McGill University researchers found training your brain in a specific, targeted, computerized way can produce important ...

2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for ...

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...

Mother of Photodynamic Therapy' and researcher with affiliations at Harvard, MGH and MIT has changed the lives of millions.

The program runs June 28 through Aug. 8 on VTSU Randolph campus and is organized into three intensive two-week sessions, with ...

RUTLAND TOWN — The VTSU Castleton Women’s Ice Hockey team will host the 17th annual Pink the Rink game against University of Southern Maine at 3 p.m. Saturday, Jan. 24, at the Spartan Arena in Rutland ...